Evaluation of Human Papilloma Virus Infection in Patients

with Esophageal Squamous Cell Carcinoma from the Caspian

Sea Area, North of Iran by Yahyapour, Yousef et al.
Asian Pacific Journal of Cancer Prevention, Vol 13, 2012 1261
   DOI:http://dx.doi.org/10.7314/APJCP.2012.13.4.1261 
HPV in Esophageal SCCs in the Caspian Sea Area, North of Iran
Asian Pacific J Cancer Prev, 13, 1261-1266
Introduction
 Human papilloma viruses (HPVs) have been concerned 
as a causal agent in a variety of human squamous cell 
carcinomas, including those of the cervix, anogenital 
region, skin, upper respiratory tract, and digestive track 
(Bosch et al., 2002; Gillison & Shah, 2003). 
 Mazandaran Province, located in the south- littoral of 
the Caspian Sea in northern Iran (Figure 1), has some of 
the highest rates of Esophageal Cancer (EC) in the world 
(Blot & McLaughlin, 1999). Nevertheless, the real causes 
and the mechanism of ESCC have not been elucidated yet.
 About 4000 esophageal squamous cell carcinomas 
(ESCCs) are diagnosed annually in the Iran. A high 
incidence Asian “esophageal cancer belt” stretching 
from Northern Iran through the central Asian republics 
to North-central China, has been identified in the world 
(Mahboubi & Kmet, 1973). The reasons for these major 
regional variations in the incidence of this disease are 
poorly understood. In western countries, where the risk 
of ESCC is generally low, consumption of tobacco and 
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Abstract
 Introduction: HPV has been found repeatedly in esophageal squamous cell carcinoma (ESCC) tissues. However, 
reported detection rates of HPV DNA in these tumors have varied markedly. Differences in detection methods, 
sample types, and geographic regions of sample origin have been suggested as potential causes of variation. We 
have reported that infection of HPV DNA in ESCC tumors depends on anatomical sites of esophagus of the 
patients from Mazandaran, north of Iran. Materials and Methods: HPV DNA was examined in 46 upper, 69 
middle and 62 lower third anatomical sites of esophageal squamous cell carcinoma specimens collected from 
Mazandaran province in north Iran, near the Caspian Littoral as a region with high incidence of ESCC. HPV 
L1 DNA was detected using Qualitative Real time PCR and MY09/MY11 primers. Results: 28.3% of upper, 
29% of middle and 25.8% of lower third of ESCC samples were positive for HPV DNA. 13.6% for males and 
14.1% for females were HPV positive in all samples. Conclusions: HPV infection is about one third of ESCC 
in this area. Findings in this study increase the possibility that HPV is involved in esophageal carcinogenesis. 
Further investigation with a larger sample size is necessary. 
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alcohol could explain more than 90% of the cases of 
ESCC (Brown et al., 2001). However, in countries with 
the highest rates of ESCC, such as Iran, China and India, 
only small proportion of ESCC could be attributed to 
smoking or alcohol consumption (Cook-Mozaffari et al., 
1979; Mir et al., 2005; Tran et al., 2005). 
 Microbial agents, especially HPV, may be one of the 
factors that explain part of this high incidence of ESCC. 
The role of HPV in ESCC has been studied in many 
high-risk and low-risk areas of the world (Lavergne & 
De Villiers, 1999; Syrjanen, 2002). Most studies from 
high-risk areas, such as China and South Africa, have 
suggested a role of HPV in ESCC, while most studies 
from low-risk areas have failed to find any association (Lu 
et al., 1991; Syrjanen, 2002). The human Papillomavirus 
(HPV) has been thought of as a possible etiological 
factor of EC since 1982 and there is a large amount of 
variation in the observations of such studies which have 
been reviewed by Syrjanen (Syrjanen, 2002). A general 
review by Syrjanen published in 2002 reported that HPV 
is positive in 22.9% of 1485 ESCC cases tested by in situ 
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hybridization (ISH) and in 15.2% of 2020 ESCC cases 
tested by PCR (Syrjanen, 2002). HPV has been found in 
variable proportions of ESCC, depending on the method 
and study areas (Syrjanen, 2002) (Table1).
     HPV DNA has been detected in 30% of human head 
and neck cancers (Gillison et al., 2000; Hansson et al., 
2005), and because the esophagus can be infected with 
these viruses in the same way as the oral cavity, tonsils, 
and pharynx, it is speculated that HPV infection might 
explain at least some esophageal cancers in humans. 
     HPV DNA detection rates in ESCC samples appear 
to be different from area to area. An explanation, offered 
by Syrjanen in his review, is the hypothesis that the 
contribution of oncogenic HPVs to ESCC risk is higher 
in the areas with high ESCC risks (Syrjanen, 1982). 
Esophageal squamous epithelium is one of the susceptible 
sites to HPV. So far, there is no report on the correlation 
of HPV infection and high incidence of esophageal 
carcinomas in Mazandaran province, north of Iran, and 
its epidemiology has not been fully studied.
 In the present study, we report the infection of HPV 
in 177 ESCC tumors depend on anatomical sites of 
esophagus of the patients from Mazandaran, Iran. Indeed, 
recent studies conducted in areas with a high ESCC risk 
showed moderately high detection rates of high-risk HPV 
DNA in cancer specimens.
Materials and Methods
 Study population and samples
 Biopsy and surgery fresh samples from patients with 
esophageal carcinoma, referred to the Department of 
Pathology, University Hospital, Babol, and Amol Central 
Pathobiology Lab., Mazandaran province, Iran, during 
2004–2011 were identified. A total of 303 specimens 
found, but 177 formalin-fixed paraffin-embedded tumor 
tissues of patients collected and entered to our study, 
and others patients were lost due to inadequate, absence 
of histological material or undefined the anatomical 
sites of esophagus. No patient had received chemo- or 
radiotherapy before endoscopies and surgery. In all cases, 
the histopathological type of tumor was squamous cell 
carcinoma. The present study is based on a retrospective 
examination of esophageal carcinoma diagnostic biopsy 
and surgery samples from clinical cases, all original 
hematoxylin and eosin (H&E) slides and/or H&E recuts 
from tissue blocks were reviewed.
Figure 1. Geographic Location of Mazandaran 
Province in the Caspian Littoral of Iran
	  
 This project was approved by the human research 
ethics committee of the Babol University of Medical 
Sciences and participating Centers, and written informed 
consent was obtained from all participants. The following 
parameters were studied: age, gender and type of sample 
(biopsy or surgery). Anatomical localization of the tumor 
was grouped into an upper part (15–24 cm), a middle part 
(25–34 cm) and a lower part of the esophagus (35–46 cm). 
Deparaffination procedure
 Paraffinated blocks from the 177 tumor samples were 
cut in 5-μm sections and 8 sections/ patient were collected 
in the same microcentrifuge tube. Samples were de-waxed 
in 500 μl xylene, All microcentrifuge tube located for 10 
min in a 60 °C heated block and centrifuged at 8,000 rpm, 
supernatant was removed. This step was then repeated 3 
times. Add 500 μl absolute ethanol, centrifuge at 10,000 
rpm for 1 min, the samples were then dried in a 60 °C 
heated block with open lids for 10-20 min for remove 
residual ethanol.
Tissue digestion
     According to samples (biopsy or surgery), 200–400 μl 
of Tissue Lysis Buffer was added to each tube [4 M Urea, 
200 mM Tris, 20 mM NaCl, 200 mM EDTA; PH=7.4 (25 
oC)]. To all tubes added 20-40 μl proteinase K, Samples 
were gently vortexed and located for 10 min in a 60 °C 
heated block, and all samples were subsequently incubated 
at 37 °C overnight. 
DNA Extraction
 The next day, 200 μl of Binding Buffer [6 M 
Guanidine-Hcl, 10mM Urea, 10mM Tris-Hcl, 20% 
Tritonx-100 (v/v); PH=4.4 (25 oC)] was added to each tube 
with gently vortex . DNA was isolated using a High Pure 
Template PCR kit (Roche Diagnostics GmbH, Mannheim, 
Germany) according to the manufacturer’s instructions. 
Extracted DNA pellets were resuspended in 100 μl of 
prewarmed Elution buffer and stored at -20 °C until use 
for Real Time PCR.
Quality Control
     The quality and concentration of DNA was measured 
Table 1. Prevalence of HPV in ESCC: Literature 
Review
Country No. of Cases   HPV Ve+  HPV Detection   Reference
                                             (%)           Method 
Iran 85 49.4 PCR 34
Iran 140 23.6 PCR 35
Sweden 100 16 Real-time PCR 37
Australia 222 3.6 PCR 38
Colombia & Chile 73 28.8 PCR 39
Iran 38 36.8 PCR 41
China 435 46.9 PCR 42
South Africa 50 46 PCR 43
China 70 33.33 Real-time PCR 44
China 700 16.9 In-situ Hybridization 45
Turkey 30 33.3 PCR 46
China 20 30 In-situ Hybridization 47
Latin American 60 25 INNO-LiPA 48
China 67 21 INNO-LiPA 49
Presence study 177 27.7 Real-time PCR -
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either on an ethidium bromide-stained 1% agarose gel 
or by standard spectrophotometric methods (Data Not 
Shown). Also, presence of DNA was confirmed by PCR 
with human β-globin primer as an internal control (Table. 
2). Hela cell line was used as a positive control for HPV 
infection. Fragments of human β-globin gene, which 
served as the internal controls, were successfully amplified 
from 129 of the 177 cancer specimens. Therefore, in 46 
samples were not present of DNA after extraction, thus 
DNA extractions of these specimens were done again. 
Also, Distilled water was used as a negative control. This 
control was necessary to determine if any of the reagents 
was contaminated with HPV DNA.
Real-time PCR 
 After DNA extraction, Real-time PCR was performed 
with the Corbett Rotor-Gene 6000 (Corbett Research, 
Australia) instrument for Real Time PCR test and three 
step with melt curve method. Approximately, 100-200 ng 
cellular DNA was utilized for Qualitative Real Time PCR. 
We used SYBR-Green PCR master mix (Maxima® SYBR 
Green qPCR Master Mix (2X), Applied Fermentas, EU). 
In brief, qualitative PCR was performed by 6 µl of purified 
DNA from each sample was added to the 6 µl PCR master 
mix with 300 pmol of each primer. The amplification 
conditions were 2 min at 50 oC, a three-step cycle of 95 
oC for 10 min (for initial denaturation), 95 oC for 15s, 55 
oC for 30 s and 72 oC for 3 s (5 repeats). For cycling 2: 95 
oC for 15 s, 55 oC for 30 s and 72 oC for 30 s for a total of 
40 cycles ,then ,melting temperature was done from 70 
oC to 99 oC and data stored for analysis melting curve. To 
examine for the presence of any HPV DNA in the tissue, 
MY09/MY11 primer pairs as a general primers were used 
to amplify the L1 gene (Table 2). For confirmed result we 
use gel agarose electrophoresis 1% that stained ethidium 
bromide. 
Statistical analysis
 Χ2 test or Fisher’s exact test was conducted using SPSS 
version 14 for the association between the presence of 
HPV genome and anatomical sites of esophagus, gender 
and age group (values P=0.05 were considered statistically 
significant).
Results
  Of 177 confirmed ESCC enrolled to our study, which is 
divided in 26%, 39% and 35% of upper, middle and lower 
third of ESCC patients, respectively. 58.8% of the patients 
in upper, 56.5% in middle and 50% in lower part of the 
esophagus were male. The age ranges in patients were 
between 35 and 91 years old. 44.1% of all patients were 
between 65 and 75 years old. Also, the table has shown 
many demographic data of patient by different parts of 
anatomical sites of ESCC patient. 42.4% of patients were 
living in urban and 57.6% were live in rural areas.
Detection of HPV in ESCC patients
 L1 consensus primer was used to detect all HPV 
infection in a total of 120 esophageal tumor biopsies and 
57 esophageal tumor surgeries obtained from Mazandaran 
province, geographic regions of Iran (Table 3). Also, there 
is a significant correlation between biopsy resections 
versus surgical in middle and lower anatomical sites of 
esophagus (P= 0.048; P=0.052) (Table 3).
 The distribution of the HPV positivity in cases with 
esophageal cancer, based on gender of the patients, were 
25.9%, 23,1% and 25.8% for males in upper, middle and 
lower part of ESCC patients. Also, the rates of HPV-DNA 
in upper, middle and lower part of ESCC in female were 
31.6%, 36.7% and 25.8%, respectively. The table that 
shown data of HPV infection in different third part of 
esophagus by age group in less than 55, 55 to 64, 65 to 74 
and +75 years old. HPV-DNA presence in ESCC was not 
significantly associated with gender and age. But, there 
is significant difference between lower part of ESCC and 
age group by HPV-DNA positive (ρ=0.067).  As the shown 
in table 6; 20%, 30.6% and 29.2% of patients in upper, 
middle and lower part of ESCC infected with HPV-DNA 
were living in urban.
Effect tumor sites on HPV prevalence
 Tumor site data was available for squamous cell 
carcinomas from the Mazandaran regions, and evaluation 
of the association between anatomic location and HPV 
prevalence was carried out in these cases. L1 was detected 
in 13 (28.3%) of carcinomas located in the upper third of 
esophagus, 20 (29%) in the middle third and 16 (25.8%) 
in the lower third. No statistically significant relationship 
between HPV infection and tumor site was found in this 
study (ρ= 0.91).
Discussion
In Western countries, where the risk of ESCC is 
generally low, consumption of tobacco and alcohol could 
explain more than 90% of the cases of ESCC (Li & Cheng, 
1984; Lu et al., 1991). However, in countries with the 
Table 2. Sequence of Primers Used
Set   Primers                        Sequences
1 MY09 5’-CGT CCM AAR GGA WAC TGA TC-3’
2 MY11 5’-GCM CAG GGW CAT AAY AAT GG-3’
3 β-Golubin (F) 5’-TGG GTT TCT GAT AGG CAC TGA CT-3’
4 β-Golubin (R) 5’-AAC AGC ATC AGG AGT GGA CAG AT-3’
Table 3. Absolute and Relative Frequency of HPV-DNA 
in Different Anatomical Sites of Esophageal SCC by 
Age Group
   Third of                        Age group (year)                    P-Value
Esophagus        <55       55-64        65-74         ≥75
                       No. %     No.  %      No. %       No. % 
Upper:  Ve+ 1  17 4 40 5 25 3 30 χ2=1.20
             Ve- 5  83 6 60 15 75 7 70 df=3
           Total 6 100 10 100 20 100 10 100 ρ=0.754
Middle: Ve+ 7  41 1    11 5 20 7 39 χ2=4.463
              Ve- 10  59 8    89 20 80 11 61 df=3
            Total 17 100 9 100 25 100 18 100 ρ=0.216
Lower:  Ve+ 5   42 4    44 2      8 5 29 χ2=7.15
              Ve- 7   58 5    56 22    92 12 71 df=3
            Total 12 100 9 100 24 100 17 100 ρ=0.067
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highest rates of ESCC, such as Iran and China, other risk 
factors such as microbial agents especially HPV may be 
some of the factors that explain part of this high incidence 
of ESCC (Lu et al., 1991; Rosai, 2004).
HPVs are oncogenic viruses and show oncogenic 
activity through spoiling mucosal immune resistance and 
destroying tumor suppresser genes (Chang et al., 1990; 
Chen et al., 1997). 
The role of HPV in ESCC has been studied in many 
high-risk and low-risk areas of the world (Gravitt et al., 
1998; Chan et al., 2001; Syrjanen, 2002; Katiyar et al., 
2005; Murtaza et al., 2006). Most studies from high-risk 
areas, such as China and South Africa, have suggested a 
role of HPV in ESCC, while most studies from low-risk 
areas have failed to find any association (Kok et al., 1997; 
Lavergne & De Villiers, 1999; Mir et al., 2007). 
There is increasing evidence suggesting that HPV 
infection is an important etiological factor in esophageal 
cancers (Chang et al., 1990; Shen et al., 2002; Ting-Ting 
et al., 2005). An association of HPV with esophageal 
carcinoma has been previously reported in many countries. 
The incidence of infection differs markedly depending on 
the different geographical location of the population under 
study and within different studies (Chang et al., 1990; 
Williamson et al., 1991; Cooper et al., 1995).
In the present study, using qualitative Real-time PCR 
with MY09/MY11 primers, we detected HPV DNA 
in 27.7% of samples different from of HPV DNA was 
positive in 49.4% of samples from north-east of Iran 
(Turkmen Sahra) in the east of Mazandaran (Golestan 
Province) (Moradi et al., 2002), where ESCC incidence 
is much higher than in Mazandaran. While, in another 
study in Tehran (South of Mazandaran), HPV DNA was 
positive in 23.6% and 36.8 % of samples in tumoral region 
of patients (Farhadi et al., 2005; Eslami et al., 2007).
According to our results, imply that HPV is not a 
predominant risk factor for ESCC in Iran because 49 
(27.7%) of all 177 samples of ESCC were positive for 
the common indicator of HPV (L1 gene). But, this is the 
first study in Iran that repots HPV infection in different 
anatomical sites of ESCC patient. 
HPV prevalence carries a close correlation to the 
incidence of SCC, being low (0-3%) and high (up to 80%) 
in the respective geographic regions (Syrjanen, 2006). 
In China the frequency of HPV in ESCC were reported 
between 6.7% and 83.3% in different parts of this country 
(Chang et al., 1990; Ting-Ting et al., 2005). However, 
the frequency of HPV infections varies significantly 
in different geographic locations in China. In a cross-
sectional study conducted in a high-risk region (Linxian) 
of China, HPV positivity was found in 16% of patients 
with severe dysplasia but never in patients with ESCC 
(Gao et al., 2006). 
Our study and Previous studies have shown HPV 
infection in different area of Iran, were nearly close 
together and different from to others reports of many 
countries. In our study prevalence of HPV L1 DNA were 
detected in 28.3%, 29% and 25.8% of upper, middle and 
lower part of esophagus in patients with ESCC. In China 
study reported, 7.5% in upper, 63.4% in middle and 29% 
in lower part of ESCC patients (Wang et al., 2010). But, In 
Sweden study, HPV L1 DNA were reported in the rates of 
27.3%, 18.2% and 6.4% of upper, middle and lower part of 
esophagus in patients with ESCC (Dreilich et al., 2006 ). 
There was high incidence of HPV infection in the 
esophageal epithelium in eastern Guangdong, southern 
China, where esophageal carcinoma is prevalent. The 
results indicate that the high incidence of esophageal 
carcinoma in this area is associated with HPV infection 
(Shen et al., 2002).
In many Western countries the results show that, in 
contrast to geographic regions where ESCC is prevalent, 
HPV infection occurs infrequently in association with 
ESCC (Turner et al., 1997).
HPV L1 DNA was detected in 24.5% of male and 
31.3% in female of patients that inrolled to our study. 
Wang and colleagues in China reported HPV L1 DNA 
in 26.6% of male and 73.3% of female (Wang et al., 
2010); whiles Dreilich and colleagues in Sweden ESCC 
patients detected HPV infection in 14.1% and 20.7% 
in male and female (Dreilich et al., 2006). This rate in 
Colombia and Chile reported by Castillo and colleague 
in male and female ESCC patients 23.1% and 35.3%, 
respectively (Castillo et al., 2006). The male: female ratio 
in HPV positive ESCC decreased in comparison with 
HPV negative cases (0.96:1 vs 1.2:1). This ratio is nearly 
similar to that reported from Colombia and Chile (0.75:1 
vs 1.1:1) (Castillo et al., 2006). However, the gender-ratio 
between HPV positive and HPV negative cases was not 
statistically significant.
34.9% of HPV L1 DNA positive in ESCC patients in 
this study were less than 65 years and 23.7% of ESCC 
patients were more than 65 years old. This rate in our study 
was similar to almost others studies that HPV infection in 
younger were more than to older patients (Castillo et al., 
2006; Dreilich et al., 2006; Wang et al., 2010).
Our results are consistent with HPV DNA studies 
conducted in other high-risk areas for ESCC which 
showed evidence of HPV in tumor tissues from 20% 
to 50% of ESCC cases and provided more evidence 
to support a causal association of HPV infection with 
esophageal squamous cell carcinoma. Also, our finding 
suggests possibility of a strong geographical difference 
in the proportion of HPV-associated ESCCs. Note, 
however, that our ESCC cases were convenient samples 
and, therefore, may not represent the ESCC cases in the 
study areas.
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